Security Snapshot

Cigna Group - Common Stock (CI) Institutional Ownership

CUSIP: 125523100

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

1,637

Shares (Excl. Options)

235,109,101

Price

$275.23

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
CI on NYSE
Shares outstanding
263,840,652
Price per share
$275.69
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
235,109,101
Total reported value
$64,715,019,898
% of total 13F portfolios
0.04%
Share change
+2,008,735
Value change
+$523,914,436
Number of holders
1,637
Price from insider filings
$275.69
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CI - Cigna Group - Common Stock is tracked under CUSIP 125523100.
  • 1637 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1,637 to 1,419 between Q4 2025 and Q1 2026.
  • Reported value moved from $64,715,019,898 to $45,949,871,343.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1637 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 125523100?
CUSIP 125523100 identifies CI - Cigna Group - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Cigna Group - Common Stock (CI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.4% $6,687,563,331 19,941,446 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $5,285,500,003 19,814,433 Vanguard Capital Management 31 Mar 2026
FMR LLC 4% $3,074,346,505 10,665,556 FMR LLC 30 Sep 2025

As of 31 Dec 2025, 1,637 institutional investors reported holding 235,109,101 shares of Cigna Group - Common Stock (CI). This represents 89% of the company’s total 263,840,652 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cigna Group - Common Stock (CI) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.9% 26,173,577 +1.6% 0.1% $7,203,753,597
BlackRock, Inc. 8.8% 23,184,007 +4.9% 0.11% $6,380,934,226
STATE STREET CORP 4.7% 12,339,250 +1.8% 0.11% $3,396,131,778
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 4.5% 11,805,083 +8.3% 1% $3,249,112,994
FMR LLC 4.3% 11,433,649 +7.2% 0.16% $3,146,883,422
Dodge & Cox 4.2% 11,138,614 +20% 1.7% $3,065,680,742
Sanders Capital, LLC 3% 7,801,089 -0.35% 2.5% $2,147,093,725
GQG Partners LLC 2.9% 7,763,295 +14% 3.5% $2,136,698,563
PRICE T ROWE ASSOCIATES INC /MD/ 2.4% 6,270,213 -45% 0.19% $1,725,752,000
GEODE CAPITAL MANAGEMENT, LLC 2.3% 6,051,370 +0.81% 0.1% $1,658,054,581
JPMORGAN CHASE & CO 2.1% 5,639,215 -15% 0.1% $1,552,081,573
NORGES BANK 1.4% 3,705,227 0.11% $1,019,789,627
MORGAN STANLEY 1.3% 3,387,860 -8% 0.06% $932,441,729
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 2,958,656 +9.8% 0.48% $814,310,891
BANK OF AMERICA CORP /DE/ 1.1% 2,925,406 +3.4% 0.06% $805,159,582
NORTHERN TRUST CORP 1% 2,751,024 -2.7% 0.1% $757,164,336
AMERIPRISE FINANCIAL INC 0.93% 2,443,642 +14% 0.15% $672,566,887
Invesco Ltd. 0.92% 2,421,775 +27% 0.1% $666,545,180
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.88% 2,325,173 +1% 0.14% $639,957,366
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 2,192,063 +4% 0.09% $603,321,532
DIMENSIONAL FUND ADVISORS LP 0.83% 2,189,878 +2.6% 0.13% $602,747,274
Legal & General Group Plc 0.77% 2,036,852 +1.3% 0.12% $560,602,783
Nuveen, LLC 0.76% 2,014,163 +14% 0.15% $554,358,083
Grantham, Mayo, Van Otterloo & Co. LLC 0.74% 1,958,134 +20% 1.4% $538,937,572
Capital Research Global Investors 0.73% 1,933,645 -39% 0.1% $532,197,113

Institutional Holders of Cigna Group - Common Stock (CI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 172,453,413 $45,949,871,343 +$255,852,931 $266.75 1,419
2025 Q4 235,109,101 $64,715,019,898 +$523,914,436 $275.23 1,637
2025 Q3 232,976,544 $67,167,655,682 -$857,214,956 $288.25 1,598
2025 Q2 234,889,680 $77,598,726,972 -$885,212,933 $330.58 1,704
2025 Q1 237,606,738 $78,165,391,200 -$1,629,993,633 $329.00 1,662
2024 Q4 243,110,253 $67,139,294,537 +$149,546,680 $276.14 1,620
2024 Q3 241,501,769 $83,663,034,570 -$782,370,817 $346.44 1,676
2024 Q2 242,938,363 $80,300,760,069 -$2,109,254,634 $330.57 1,640
2024 Q1 249,797,666 $90,679,981,393 -$1,122,160,345 $363.19 1,636
2023 Q4 254,905,490 $76,350,472,759 -$323,521,351 $299.45 1,607
2023 Q3 255,571,910 $73,157,868,502 -$415,321,371 $286.07 1,478
2023 Q2 256,478,311 $71,887,572,718 +$121,205,524 $280.60 1,472
2023 Q1 256,474,460 $65,550,273,339 -$1,402,712,627 $255.53 1,457
2022 Q4 261,971,976 $86,695,724,570 -$2,552,637,868 $331.34 1,529
2022 Q3 270,855,350 $75,242,136,697 -$1,620,088,258 $277.47 1,452
2022 Q2 276,429,732 $72,853,453,449 -$283,725,559 $263.52 1,410
2022 Q1 278,899,427 $66,890,029,883 -$1,137,305,493 $239.61 1,346
2021 Q4 283,619,322 $65,152,838,427 -$1,812,537,350 $229.63 1,307
2021 Q3 291,305,903 $58,341,683,644 -$2,024,570,950 $200.16 1,219
2021 Q2 300,814,030 $71,290,214,867 -$1,665,379,799 $237.07 1,262
2021 Q1 307,283,997 $74,271,008,939 -$1,668,241,583 $241.74 1,216
2020 Q4 315,379,158 $65,634,524,310 -$626,660,034 $208.18 1,175
2020 Q3 319,448,567 $54,030,116,575 -$2,336,334,165 $169.41 1,089
2020 Q2 332,373,272 $62,333,055,611 +$389,410,042 $187.65 1,131
2020 Q1 330,640,915 $58,568,219,801 -$573,938,971 $177.18 1,105
2019 Q4 333,347,680 $68,149,790,920 +$764,945,588 $204.49 1,148
2019 Q3 328,919,099 $49,917,839,260 -$549,118,085 $151.79 1,018
2019 Q2 332,629,799 $52,411,348,146 -$84,749,971 $157.55 1,031
2019 Q1 336,095,513 $54,037,429,873 +$225,933,374 $160.82 1,063
2018 Q4 332,747,054 $63,187,552,217 +$63,024,351,645 $189.92 1,117
2018 Q3 3,821 $738,099 +$4,998 $208.25 6
2018 Q2 3,797 $669,426 -$1,436,787 $169.95 6
2018 Q1 12,737 $2,101,708 +$1,476,355 $167.74 7
2017 Q4 3,562 $675,935 -$24,108 $202.69 6
2017 Q3 3,681 $676,005 +$386,000 $186.94 6
2017 Q2 1,549 $258,553 +$7,500 $167.39 5
2017 Q1 1,504 $220,757 -$5,024 $146.49 5
2016 Q4 1,538 $204,723 -$12,735 $133.39 5
2016 Q3 1,419 $184,432 -$6,516 $130.15 4
2016 Q2 1,092 $140,000 -$134,560 $127.99 3
2016 Q1 2,014 $288,594 $137.47 4
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .